KLF13 polyclonal antibody

Represses transcription by binding to the BTE site, a GC-rich DNA element, in competition with the activator SP1.

9007-83-4

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide, pH 7.3.

Q9Y2Y9

Human, Mouse

The antiserum was produced against synthesized peptide derived from human KLF13 around the non-acetylation site of Lys166. AA range:131-180

Unconjugated

WB, IHC-P, ELISA

WB: 1/500-1/1000 IHC: 1/50-1/100 ELISA: 1/10000

Affinity Purified

Unmodified

Calculated MW: 31 kDa; Observed MW: 31 kDa

Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

For research use only, not for use in diagnostic procedure.

IgG

Western blot analysis of KLF13 in L929 lysates using KLF13 antibody.

Rabbit